Aravive Inc (NASDAQ:ARAV)
| 0.99 Delayed Data As of Aug 08 |  +0.0693 / +7.53%Today’s Change | 0.80 Today|||52-Week Range 4.40 | -54.79% Year-to-Date |
Latest ARAV News | Press Releases
No recent news for Aravive Inc.
Today’s Trading
| Previous close | 0.92 |
| Today’s open | 0.97 |
| Day’s range | 0.97 - 1.04 |
| Volume | 2,357 |
| Average volume (3 months) | 86,512 |
| Market cap | $26.7M |
Data as of 4:00pm ET, 08/08/2022
Growth & Valuation
| Earnings growth (last year) | -0.85% |
| Earnings growth (this year) | -25.74% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +30.91% |
| P/E ratio | NM |
| Price/Sales | 5.91 |
| Price/Book | 0.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LRMRLarimar Therapeutics... | +0.41 | +26.80% |
| CLCSCell Source Inc | 0.00 | 0.00% |
| ---- | ||
| AGLEAeglea Bio Therapeut... | +0.01 | +2.00% |
Data as of 3:59pm ET, 08/08/2022
Financials
| Last reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$0.59 |
| Annual revenue (last year) | $7.4M |
| Annual profit (last year) | -$39.2M |
| Net profit margin | -526.08% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Houston, Texas |
Forecasts
